Key result
Early vv-ECMO shows no significant in-hospital mortality benefit compared with late implantation.
Why the study?
Outcomes of veno-venous ECMO for severe therapy-refractory COVID-19-related ARDS remain unsatisfactory, and prolonged pre-ECMO mechanical ventilation may cause further lung damage and impair outcomes.
Does early veno-venous ECMO implantation (≤2 days after intubation) improve survival and weaning rates compared to delayed implantation (>2 days) in critically ill patients with severe COVID-19-related ARDS?
Cohort (n=76)
No
Does early veno-venous ECMO implantation (≤2 days after intubation) improve survival and weaning rates compared to delayed implantation (>2 days) in critically ill patients with severe COVID-19-related ARDS?
Early initiation of veno-venous ECMO within 2 days of intubation in severe COVID-19 ARDS patients was associated with a non-significant trend toward improved in-hospital survival and higher weaning rates without increasing severe ECMO-related adverse events.
Answers are grounded in this paper and cite their sources.
Should not change vv-ECMO timing practice in COVID-19 ARDS; hypothesis-generating and requires randomized confirmation.
All articles of this category Background: Since March 2020, COVID-19 pandemic has tremendously challenged the global health care system. In patients with severe therapy-refractory acute respiratory distress syndrome (ARDS), veno-venous extracorporeal membrane oxygenation (vv-ECMO) remains the ultimo ratio therapy; however, the outcome is still not satisfying. Prolonged mechanically ventilation of ARDS patients, especially with high driving pressure, may further damage the lung and contributes to impaired outcome. Method: Between 2020 and 2022, a total of 82 patients were treated with vv-ECMO for severe COVID-19-related ARDS in our department. The patients were prospectively enrolled into an institutional database and subsequent retrospectively reviewed. Patients were divided Patients were divided in regard to the duration of pre-ECMO mechanically ventilation (Group 1 [≤2 days]: n = 40; Group 2 [>2 days]: n = 36). The remaining n = 6 patients were excluded due to awake ECMO implantation. Results: Except gender (Group 1: 22.5% female, Group 2: 58.3% female, p < 0.01), baseline characteristics such as demographic data and concomitant diseases were comparable between the two groups. The mean duration between the onset of the first COVID-19 related symptoms and ECMO implantation was 14 ± 7 days and between intubation and ECMO implantation 0.8 ± 0.8 days for Group 1 compared with 18 ± 7 days ( p = 0.04), respectively, 7.6 ± 4.3 days ( p < 0.001) for Group 2. We did not observed differences regarding the incidence of severe ECMO-related adverse events in regard to the pre-ECMO mechanical ventilation time. However, successful ECMO weaning rate was numerically increased in Group 1 (42.5%) compared with Group 2 (25.0%, p = 0.15) with shorter support time until weaning (Group 1: 16 ± 13 days, Group 2: 44 ± 44 days, p = 0.08). A similar trend was also found for in-hospital death (Group 1: 60.0%, Group 2: 77.8%, p = 0.08). Conclusion: Early ECMO implantation after orotracheal intubation for severe COVID-19-related ARDS did not affect the peri-interventional morbidity. However, we observed a numerically increased weaning rate as well as increased survival in patients with early ECMO implantation after intubation. As lung-protective ventilation can be achieved by early ECMO implantation in COVID-19 patients, it potentially decreases the ventilator-associated lung damage. Publication History Article published online: 28 January 2023 © 2023. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
No takes yet. Share an insight, caveat, or question.
Immohr et al. (2023) conducted a cohort in Severe COVID-19-related acute respiratory distress syndrome (ARDS) (n=76). Early veno-venous ECMO implantation (≤2 days of pre-ECMO mechanical ventilation) vs. Late veno-venous ECMO implantation (>2 days of pre-ECMO mechanical ventilation) was evaluated on In-hospital death (p=0.08). Early vv-ECMO implantation (≤2 days after intubation) showed a trend toward lower in-hospital death and higher weaning rates compared to >2 days.
Synapse has enriched 10 related papers. Consider them for comparative context: